Cellectis Balance Sheet Health
Financial Health criteria checks 5/6
Cellectis has a total shareholder equity of $129.4M and total debt of $44.7M, which brings its debt-to-equity ratio to 34.5%. Its total assets and total liabilities are $395.9M and $266.5M respectively.
Key information
34.5%
Debt to equity ratio
US$44.68m
Debt
| Interest coverage ratio | n/a |
| Cash | US$159.09m |
| Equity | US$129.42m |
| Total liabilities | US$266.45m |
| Total assets | US$395.88m |
Recent financial health updates
No updates
Recent updates
Cellectis: Cheap With Promising But Speculative Cancer Therapies
Aug 30Cellectis: 2 Data Readouts Of Blood Cancer Studies By End Of 2024
May 30FDA clears Cellectis' investigational new drug application for lymphoma treatment
Aug 01Cellectis Offers An Idiosyncratic Risk Profile With Remarkable Upside Potential
Jul 13Cellectis: FYE 2021 TALEN CAR-T Data Announcement Should Catalyse Strong Upside
Jun 22Cellectis outlines four new UCART preclinical programs; reveals .HEAL, a genome surgery platform
Jun 15Cellectis withdraws follow-on offering
Dec 16Cellectis initiates equity raise of $100M
Dec 14FDA lifts clinical hold on Cellectis' early-stage UCARTCS1 study in multiple myeloma
Nov 18Cellectis EPS misses by $0.10, misses on revenue
Nov 05Financial Position Analysis
Short Term Liabilities: CLLS's short term assets ($294.4M) exceed its short term liabilities ($165.7M).
Long Term Liabilities: CLLS's short term assets ($294.4M) exceed its long term liabilities ($100.8M).
Debt to Equity History and Analysis
Debt Level: CLLS has more cash than its total debt.
Reducing Debt: CLLS's debt to equity ratio has increased from 0% to 34.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CLLS has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CLLS is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 14.1% per year.